Provided by Tiger Trade Technology Pte. Ltd.

ZAI LAB

19.250
+0.0600.31%
Volume:4.91M
Turnover:93.87M
Market Cap:21.91B
PE:-120.12
High:19.350
Open:19.300
Low:18.930
Close:19.190
52wk High:26.080
52wk Low:12.310
Shares:1.14B
HK Float Shares:1.14B
Volume Ratio:1.54
T/O Rate:0.43%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.160
ROE:-26.91%
ROA:-14.75%
PB:4.60
PE(LYR):-120.12
PS:6.21

Loading ...

Asian Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

MT Newswires Live
·
Oct 08

Zai Lab: RTW Fund Group GP, LLC Acquires US ADR Shares

HK Disclosure
·
Oct 08

ZAI LAB: The Goldman Sachs Group, Inc. Acquires Shares, Long Position Rises to 5.33%

HK Disclosure
·
Oct 08

ZAI LAB: RTW Investments, LP Acquires Shares

HK Disclosure
·
Oct 08

HK Movers | Biopharma Stocks Fall Across the Board, GENSCRIPT BIO Plunges Over 14%, JOINN Drops More Than 12%

Tiger Newspress
·
Oct 07

Movement Alert|ZAI LAB Falls 5.82% in Regular Trading, Biotech Sector Weakens After ESMO Catalyst Fades and Goldman Sachs Trims Stake

Market Focus
·
Oct 07

Movement Alert|ZAI LAB Intraday Rise 5.4% at Open, Innovation Therapeutics Sector Sees Diversified Catalysts

Market Focus
·
Oct 06

Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; End Week Flat

MT Newswires Live
·
Oct 02

ZAI LAB: The Goldman Sachs Group, Inc. Disposes of Shares, Long

HK Disclosure
·
Oct 02

Movement Alert|ZAI LAB Falls 6.15% in Regular Trading, Biotech Sector Under Broad Selling Pressure Amid Weak Fundamentals

Market Focus
·
Oct 02

Zai Lab to Present First Global Data on DLL3 ADC Zocilurtatug Pelitecan in First-Line ES-SCLC Trial at ESMO 2026

Reuters
·
Sep 29

Zai Lab to Present First Global Data from Clinical Trial Evaluating Zocilurtatug Pelitecan (Zoci) as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer (Es-Sclc)

THOMSON REUTERS
·
Sep 29

Zai Lab Ltd.: JPMorgan Chase & Co. Disposes of Shares, Long Position Falls to 10.7%

HK Disclosure
·
Sep 23

ZAI LAB: The Goldman Sachs Group, Inc. Disposes of Shares, Long Position Falls to 4.97%

HK Disclosure
·
Sep 23

HK Stocks in Focus: Biopharma Sector Surges as 10 Ministries Unveil 15th Five-Year Plan; Analysts See Potential 'Claude Moment' for Industry

Stock News
·
Sep 18

Big Pharma is Pouring Billions into China's Biotechs

Dow Jones
·
Sep 14

Zai Lab Allocates Restricted Stock Units Under Equity Plan

Stock News
·
Sep 11

Zai Lab Grants 15,600 RSUs Under 2024 Equity Incentive Plan

Reuters
·
Sep 11

Movement Alert|ZAI LAB Falls 5.1% in Regular Trading, H1 Net Loss Widens 14% Amid Biotech Sector Sell-Off

Market Focus
·
Sep 10

Zai Lab Maintains Share Count in August; 1.43 Million Options Exercised, Raises USD 2.49 Million

Bulletin Express
·
Sep 04